Award
National Heart, Lung, and Blood Institute 5F31HL178162-02
Attenuation of sepsis-induced microvascular permeability and inflammation with the GLP-1R agonist liraglutide.
Recipient
Vanderbilt University, Nashville, TN, United States
Award Amount
$38,298.00
Ceiling
$38,298.00
Awarded
May 25, 2026
Identifier
5F31HL178162-02
The award supports research on liraglutide's potential to reduce microvascular permeability and inflammation in sepsis by protecting endothelial barriers and modulating inflammatory pathways.
Description
This project aims to study the effects of the GLP-1R agonist liraglutide on sepsis-induced microvascular permeability and inflammation, focusing on endothelial barrier protection and anti-inflammatory mechanisms in sepsis.